WO2020139057A3 - Composition for preventing and treating muscle disease or improving muscle function, comprising illicium verum extract or shikimic acid - Google Patents

Composition for preventing and treating muscle disease or improving muscle function, comprising illicium verum extract or shikimic acid Download PDF

Info

Publication number
WO2020139057A3
WO2020139057A3 PCT/KR2019/018726 KR2019018726W WO2020139057A3 WO 2020139057 A3 WO2020139057 A3 WO 2020139057A3 KR 2019018726 W KR2019018726 W KR 2019018726W WO 2020139057 A3 WO2020139057 A3 WO 2020139057A3
Authority
WO
WIPO (PCT)
Prior art keywords
muscle
preventing
shikimic acid
treating
composition
Prior art date
Application number
PCT/KR2019/018726
Other languages
French (fr)
Korean (ko)
Other versions
WO2020139057A2 (en
Inventor
황재관
김창희
유지희
Original Assignee
연세대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020190076670A external-priority patent/KR20200083146A/en
Application filed by 연세대학교 산학협력단 filed Critical 연세대학교 산학협력단
Publication of WO2020139057A2 publication Critical patent/WO2020139057A2/en
Publication of WO2020139057A3 publication Critical patent/WO2020139057A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Abstract

The present invention relates to a composition for preventing and treating a muscle disease or improving muscle function, comprising an Illicium verum extract and shikimic acid. The Illicium verum extract and shikimic acid according to the present invention have the effect of increasing activity of mTOR involved in muscle protein synthesis and reducing the mRNA expression of MuRF-1 and atrogin-1 involved in muscle protein degradation, and increase muscle mass and enhance muscle function, thereby being useful for preventing, treating, or alleviating various muscle diseases such as atony, muscular atrophy, muscular dystrophy, muscular degeneration, myasthenia, cachexia, and sarcopenia.
PCT/KR2019/018726 2018-12-28 2019-12-30 Composition for preventing and treating muscle disease or improving muscle function, comprising illicium verum extract or shikimic acid WO2020139057A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20180172731 2018-12-28
KR10-2018-0172731 2018-12-28
KR1020190076670A KR20200083146A (en) 2018-12-28 2019-06-26 Composition for prevention and treatment of muscular disorder or improvement of muscular functions comprising Illicium verum extract or shikimic acid
KR10-2019-0076670 2019-06-26

Publications (2)

Publication Number Publication Date
WO2020139057A2 WO2020139057A2 (en) 2020-07-02
WO2020139057A3 true WO2020139057A3 (en) 2020-08-20

Family

ID=71126648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/018726 WO2020139057A2 (en) 2018-12-28 2019-12-30 Composition for preventing and treating muscle disease or improving muscle function, comprising illicium verum extract or shikimic acid

Country Status (2)

Country Link
KR (1) KR102352636B1 (en)
WO (1) WO2020139057A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138607A1 (en) * 2006-05-25 2007-12-06 Iyer Sankar V Method for obtaining shikimic acid
JP2009215266A (en) * 2008-03-12 2009-09-24 Kose Corp Skin lightening agent containing shikimic acid as beneficial ingredient
WO2014024140A1 (en) * 2012-08-08 2014-02-13 Koninklijke Philips N.V. Led-based phototherapy panel capable of fitting in an x-ray cassette tray of an incubator
KR20150024606A (en) * 2013-08-27 2015-03-09 영남대학교 산학협력단 Composition for inhibiting cellular senescence comprising extracts of Anisi Stellati Fructus or threo-1(4'-methoxyphenyl)-1,2-propandiol isolated from the same
KR20150044607A (en) * 2013-10-17 2015-04-27 (주)아모레퍼시픽 Method for derivation of inducible Pluripotent stem cells and inducible Pluripotent stem cells produced using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6603133B2 (en) * 2013-02-06 2019-11-06 ブランダイス ユニバーシティー Treatment of DNA damage and mitochondrial dysfunction using palm fruit

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007138607A1 (en) * 2006-05-25 2007-12-06 Iyer Sankar V Method for obtaining shikimic acid
JP2009215266A (en) * 2008-03-12 2009-09-24 Kose Corp Skin lightening agent containing shikimic acid as beneficial ingredient
WO2014024140A1 (en) * 2012-08-08 2014-02-13 Koninklijke Philips N.V. Led-based phototherapy panel capable of fitting in an x-ray cassette tray of an incubator
KR20150024606A (en) * 2013-08-27 2015-03-09 영남대학교 산학협력단 Composition for inhibiting cellular senescence comprising extracts of Anisi Stellati Fructus or threo-1(4'-methoxyphenyl)-1,2-propandiol isolated from the same
KR20150044607A (en) * 2013-10-17 2015-04-27 (주)아모레퍼시픽 Method for derivation of inducible Pluripotent stem cells and inducible Pluripotent stem cells produced using the same

Also Published As

Publication number Publication date
KR20200083354A (en) 2020-07-08
WO2020139057A2 (en) 2020-07-02
KR102352636B1 (en) 2022-01-19

Similar Documents

Publication Publication Date Title
AU2018338314A1 (en) Protein degraders and uses thereof
AU2018284960A1 (en) AADC polynucleotides for the treatment of Parkinson's disease
EP3934652A4 (en) Compounds, compositions, and methods for the treatment of disease
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
AU2018247351B2 (en) Methods and compositions for treatment of demyelinating diseases
WO2020102646A3 (en) Inhibitors of arg1 and/or arg2
EP4233910A3 (en) Methods of treatment of cholestatic diseases
EP3976595A4 (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
EA201490748A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LACHINIMODA AND FINGOLIMODA
EP4031152A4 (en) Methods and probiotic compositions for the treatment of metabolic diseases and disorders
EP3908374A4 (en) Compositions and methods for diagnosis and treatment of neurodegenerative diseases
EA201890815A1 (en) AMINO ACID COMPOSITIONS WITH MODIFIED DELIVERY FOR ORAL ADMINISTRATION
EP3681477A4 (en) Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
CR20220215A (en) Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
WO2010129048A3 (en) Therapeutic compounds
EP4233913A3 (en) Improved bromocriptine formulations
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3793566A4 (en) Compositions and methods for reducing spliceopathy and treating rna dominance disorders
WO2021100029A3 (en) Prodrugs of fulvestrant
EA201892098A1 (en) COMPOUND POSSESSING INHIBITING MUTANT IDH ACTIVITY, METHOD FOR PRODUCING AND APPLICATION
MX2020008991A (en) Methods for altering body composition.
EP3643302A4 (en) Composition containing sesquiterpene derivative as active ingredient for prevention or treatment of muscle diseases
WO2020139057A3 (en) Composition for preventing and treating muscle disease or improving muscle function, comprising illicium verum extract or shikimic acid
WO2021041324A3 (en) Compositions and methods for the treatment of pathological pain and itch
WO2019155360A3 (en) Pharmaceutical composition for treating bacterial and viral infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19902869

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19902869

Country of ref document: EP

Kind code of ref document: A2